Clinical and genetic issues in familial dilated cardiomyopathy
- PMID: 15808750
- DOI: 10.1016/j.jacc.2004.11.066
Clinical and genetic issues in familial dilated cardiomyopathy
Abstract
Idiopathic dilated cardiomyopathy (IDC) is characterized by left ventricular dilatation and systolic dysfunction after known causes have been excluded. Idiopathic dilated cardiomyopathy occurring in families, or familial dilated cardiomyopathy (FDC), may occur in 20% to 50% of IDC cases. Sixteen genes have been shown to cause autosomal dominant FDC, but collectively may account for only a fraction of genetic causation; it is anticipated that additional genes causative of FDC will be discovered. Familial dilated cardiomyopathy demonstrates incomplete penetrance, variable expression, and significant locus and allelic heterogeneity, making clinical and genetic diagnosis complex. Echocardiographic and electrocardiographic screening of first-degree relatives of individuals with IDC and FDC is indicated, as detection and treatment are possible before the onset of advanced symptomatic disease. Genetic counseling for IDC and FDC is also indicated to assist with family evaluations for genetic disease and with the uncertainty and anxiety surrounding the significance of clinical and genetic evaluation. Genetic testing is not yet commonly available, but its emergence will provide new opportunities for presymptomatic diagnosis.
Comment in
-
Viruses and other environmental factors as possible sources of phenotypic heterogeneity in familial dilated cardiomyopathy.J Am Coll Cardiol. 2006 Feb 7;47(3):689-90; author reply 690. doi: 10.1016/j.jacc.2005.11.004. J Am Coll Cardiol. 2006. PMID: 16458162 No abstract available.
Similar articles
-
Genetic Counseling and Screening Issues in Familial Dilated Cardiomyopathy.J Genet Couns. 2001 Oct;10(5):397-415. doi: 10.1023/A:1016641504606. J Genet Couns. 2001. PMID: 26141267
-
Clinical profiles of four large pedigrees with familial dilated cardiomyopathy: preliminary recommendations for clinical practice.J Am Coll Cardiol. 1999 Sep;34(3):837-47. doi: 10.1016/s0735-1097(99)00276-4. J Am Coll Cardiol. 1999. PMID: 10483968
-
Update 2011: clinical and genetic issues in familial dilated cardiomyopathy.J Am Coll Cardiol. 2011 Apr 19;57(16):1641-9. doi: 10.1016/j.jacc.2011.01.015. J Am Coll Cardiol. 2011. PMID: 21492761 Free PMC article. Review.
-
Periodic rescreening is indicated for family members at risk of developing familial dilated cardiomyopathy.J Am Coll Cardiol. 2002 May 1;39(9):1503-7. doi: 10.1016/s0735-1097(02)01788-6. J Am Coll Cardiol. 2002. PMID: 11985914
-
Cardiomyopathy, familial dilated.Orphanet J Rare Dis. 2006 Jul 13;1:27. doi: 10.1186/1750-1172-1-27. Orphanet J Rare Dis. 2006. PMID: 16839424 Free PMC article. Review.
Cited by
-
The Role of Genetics in Risk Stratification Strategy of Dilated Cardiomyopathy.Rev Cardiovasc Med. 2022 Sep 9;23(9):305. doi: 10.31083/j.rcm2309305. eCollection 2022 Sep. Rev Cardiovasc Med. 2022. PMID: 39077708 Free PMC article. Review.
-
Heart in Disguise: Unmasking a Novel Gene Deletion in Dilated Cardiomyopathy.Cureus. 2024 Feb 28;16(2):e55170. doi: 10.7759/cureus.55170. eCollection 2024 Feb. Cureus. 2024. PMID: 38562263 Free PMC article.
-
Familial dilated cardiomyopathy in a child: a case report.BMC Pediatr. 2024 Apr 1;24(1):226. doi: 10.1186/s12887-024-04614-4. BMC Pediatr. 2024. PMID: 38561731 Free PMC article.
-
A novel combination of filamin C mutation and cardiorespiratory sarcoidosis in a patient with left ventricular systolic dysfunction.BMJ Case Rep. 2024 Jan 2;17(1):e257482. doi: 10.1136/bcr-2023-257482. BMJ Case Rep. 2024. PMID: 38167413
-
Case report: A new de novo mutation of the Troponin T2 gene in a Chinese patient with dilated cardiomyopathy.Front Cardiovasc Med. 2023 Nov 20;10:1288328. doi: 10.3389/fcvm.2023.1288328. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 38054088 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
